DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 0.00 0.00%
S&P 500 2,088.77 6.89 0.33%
market minute promo

Sanofi (ADR) (NYSE: SNY)

46.15 -0.20 (-0.43%)

REAL-TIME: Last trade at

Extended Hours: $46.04 -$0.11 (-0.24%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

SNY $46.15 -0.43%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.20
Previous Close $46.35
Daily Range $46.01 - $46.39
52-Week Range $44.24 - $57.42
Market Cap $121.9B
P/E Ratio 24.92
Dividend (Yield) $1.91 (2.8%)
Ex-Dividend Date
Dividend Pay Date
05/07/14
06/05/14
Volume 693,274
Average Daily Volume 2,644,209
Current FY EPS $3.23

Sector

Healthcare

Industry

Drugs

Sanofi (ADR) (SNY) Description

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website: http://www.sanofi.com/

News & Commentary Rss Feed

Could MannKind Corporation Be a Top Stock in 2015?

MannKind headed into 2014 with high hopes but largely fizzled out in the second half of the year. Are the stars aligned for MannKind to have an exceptional year, or will it be more of the same for shareholders?

Guru Stocks at 52-Week Lows: HSBC, SNY, WBK, DCM, BBVA

Anika Therapeutics: U.S. Approval To Drive Profit And Valuation

Alnylam Pharmaceuticals Continues To Post Encouraging Results

Overvalued Bonds Or Would You Buy Stocks With A PE Of 100?

Buying These 3 Stocks Is Like Making a Bet in a Burning House

Aegerion Pharmaceuticals, MannKind Corp., and VIVUS, Inc. have all attracted short sellers in droves this year. With each company facing serious headwinds, should investors avoid these struggling biotechs?

Why Is George Soros Buying This Beaten Down Biotech Stock?

Soros Fund Management opened a position in the struggling biotech Aegerion Pharmaceuticals in the third quarter, even while the drugmaker's revenue estimates continued to plummet. Should retail investors follow his lead into this beaten down biotech?

European ADRs Lower on Banking Losses

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?

In this week's Industry Focus, our analysts discuss their favorites of the successful 2014 healthcare large-cap stocks.

Cramer's Lightning Round - Why Did They Fire The Nice Man At Sanofi? (12/17/14)

See More SNY News...

SNY's Top Competitors

SNY $46.15 (-0.43%)
Current stock: SNY
JNJ $105.06 (0.45%)
Current stock: JNJ
GSK $43.15 (0.70%)
Current stock: GSK
AZN $70.91 (0.67%)
Current stock: AZN